We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+0.98%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$8.92B
AUM Growth
+$174M
Cap. Flow
+$150M
Cap. Flow %
1.68%
Top 10 Hldgs %
9.99%
Holding
2,113
New
656
Increased
339
Reduced
297
Closed
567

Top Buys

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$23.1M
2
Z icon
Zillow
Z
+$21.8M
3
DVN icon
Devon Energy
DVN
+$20.9M
4
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$16.6M
5
TECK icon
Teck Resources
TECK
+$16.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.8%
2 Healthcare 3.21%
3 Technology 2.72%
4 Energy 2.29%
5 Materials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPLT icon
1501
Katapult Holdings
KPLT
$806M
$64K ﹤0.01%
760
NXDR
1502
Nextdoor Holdings
NXDR
$963M
$63K ﹤0.01%
+8,000
New +$82.6K
NVCR icon
1503
NovoCure
NVCR
$1.94B
$60K ﹤0.01%
+794
New +$79.7K
UP icon
1504
Wheels Up
UP
$130M
$60K ﹤0.01%
+65
New +$75.9K
DMK
1505
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$60K ﹤0.01%
1,429
ABUS icon
1506
Arbutus Biopharma
ABUS
$993M
$59K ﹤0.01%
15,097
+8,199
+119% +$31.8K
SVM
1507
Silvercorp Metals
SVM
$2.64B
$57K ﹤0.01%
15,000
FTK icon
1508
Flotek Industries
FTK
$1.14B
$56K ﹤0.01%
+8,333
New +$47.3K
ASXC
1509
DELISTED
Asensus Surgical, Inc.
ASXC
$56K ﹤0.01%
50,000
+20,000
+67% +$30.9K
CALA
1510
DELISTED
Calithera Biosciences, Inc
CALA
$55K ﹤0.01%
+4,081
New +$103K
CFRX
1511
CALL
DELISTED
ContraFect Corporation
CFRX
$53K ﹤0.01%
250
PSTH
1512
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$49K ﹤0.01%
+2,500
New +$49.6K
STIM icon
1513
CALL
Neuronetics
STIM
$221M
$46K ﹤0.01%
10,400
DNN icon
1514
Denison Mines
DNN
$2.59B
$45K ﹤0.01%
32,700
-377,300
-92% -$619K
WOW
1515
DELISTED
WideOpenWest
WOW
$45K ﹤0.01%
+2,084
New +$41.5K
PGEN icon
1516
Precigen
PGEN
$2.79B
$44K ﹤0.01%
11,882
LOCL.WS
1517
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$42K ﹤0.01%
+62,144
New +$54.8K
CRXTW
1518
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$41K ﹤0.01%
140,821
ISRG icon
1519
Intuitive Surgical
ISRG
$139B
$37K ﹤0.01%
+100
New +$34.4K
FIGS icon
1520
FIGS
FIGS
$2.17B
$36K ﹤0.01%
+1,300
New +$42.8K
NNDM
1521
Nano Dimension
NNDM
$331M
$35K ﹤0.01%
+9,000
New +$45.7K
BLNK icon
1522
Blink Charging
BLNK
$86.8M
$34K ﹤0.01%
+1,300
New +$41.9K
NKTR icon
1523
Nektar Therapeutics
NKTR
$2.29B
$33K ﹤0.01%
161
-1,572
-91% -$341K
RGS icon
1524
Regis Corp
RGS
$66.8M
$29K ﹤0.01%
+807
New +$43.8K
FTK icon
1525
PUT
Flotek Industries
FTK
$1.14B
$28K ﹤0.01%
+4,167
New +$23.7K

Similar funds

Caption Management's Q4 2021 Portfolio in Review

As of Q4 2021, Caption Management held 2,113 positions worth $8.92B, up 2% from $8.75B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Caption Management's Q4 2021 filing shows 656 new, 339 increased, 297 reduced and 567 closed positions. Its largest new stake was Zillow: 302,083 shares worth $19.3M. The largest sale was Meta Platforms (Facebook), an estimated $33.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.

  • Caption Management's largest Q4 2021 buy was Zillow: 302,083 shares worth $19.3M.
  • Caption Management added most to Trip.com Group in Q4 2021, an estimated $23.1M increase.
  • Caption Management's biggest Q4 2021 reduction was Charter Communications, cutting an estimated $22.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q4 2021, selling an estimated $33.2M.
  • Caption Management's ten largest holdings make up 10% of its $8.92B portfolio in Q4 2021.
  • Caption Management opened 656 new positions and closed 567 in Q4 2021.
  • Caption Management's portfolio value rose 2% quarter-over-quarter to $8.92B.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.